Alexandra C. Pedraza
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Ultra-widefield retinal imaging for early detection of asymptomatic cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation: a prospective pilot feasibility study.
Journal: Journal of ophthalmic inflammation and infection
Published: February 09, 2026
Red blood cell immunization as an independent predictor of survival in the myelodysplastic syndromes.
Journal: British journal of haematology
Published: October 06, 2025
Avatrombopag for post-transplant thrombocytopenia following allogeneic haematopoietic stem cell transplantation: A single-centre retrospective study.
Journal: British journal of haematology
Published: October 01, 2025
Modifying Post-Transplant Cyclophosphamide Platform to Improve Safety in HLA-Matched Allogeneic HCT: A Reduced Dose Plus Adjunctive Strategies.
Journal: Transplantation and cellular therapy
Published: July 23, 2025
Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on Infectious Complications and Immune Reconstitution According to Donor Type.
Journal: Cancers
Published: February 14, 2025
Optimized GVHD Prevention in HLA-Mismatched Unrelated Allogeneic HCT Using a PTCY-Based Approach.
Journal: European journal of haematology
Published: November 20, 2024
Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide based prophylaxis.
Journal: European journal of haematology
Published: June 15, 2024
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation.
Journal: Bone marrow transplantation
Published: April 19, 2024
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH).
Journal: Transplantation and cellular therapy
Published: February 29, 2024
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: December 18, 2023
At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 17, 2023
Last Updated: 09/26/2026